The RUNX genes: gain or loss of function in cancer
K Blyth, ER Cameron, JC Neil - Nature Reviews Cancer, 2005 - nature.com
The RUNX genes have come to prominence recently because of their roles as essential
regulators of cell fate in development and their paradoxical effects in cancer, in which they …
regulators of cell fate in development and their paradoxical effects in cancer, in which they …
Genetics of myeloid malignancies: pathogenetic and clinical implications
S Fröhling, C Scholl, DG Gilliland… - Journal of clinical …, 2005 - ascopubs.org
Myeloid malignancies are clonal disorders that are characterized by acquired somatic
mutation in hematopoietic progenitors. Recent advances in our understanding of the genetic …
mutation in hematopoietic progenitors. Recent advances in our understanding of the genetic …
Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia
SE Mullican, S Zhang, M Konopleva, V Ruvolo… - Nature medicine, 2007 - nature.com
Abstract Nur77 (NR4A1) and Nor-1 (NR4A3) are highly homologous orphan nuclear
receptors, that regulate the transcription of overlapping target genes,. The transcriptional …
receptors, that regulate the transcription of overlapping target genes,. The transcriptional …
Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7
A Nagamachi, H Matsui, H Asou, Y Ozaki, D Aki… - Cancer cell, 2013 - cell.com
Monosomy 7 and interstitial deletion of 7q (− 7/7q−) are well-recognized nonrandom
chromosomal abnormalities frequently found among patients with myelodysplastic …
chromosomal abnormalities frequently found among patients with myelodysplastic …
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML
Epigenetic regulators, such as EZH2, are frequently mutated in cancer, and loss-of-function
EZH2 mutations are common in myeloid malignancies. We have examined the importance …
EZH2 mutations are common in myeloid malignancies. We have examined the importance …
Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development
A Burchert, Y Wang, D Cai, N Von Bubnoff, P Paschka… - Leukemia, 2005 - nature.com
BCR/ABL-kinase mutations frequently mediate clinical resistance to the selective tyrosine
kinase inhibitor Imatinib mesylate (IM, Gleevec®). However, mechanisms that promote …
kinase inhibitor Imatinib mesylate (IM, Gleevec®). However, mechanisms that promote …
Epigenetic modifications in acute myeloid leukemia: prognosis, treatment, and heterogeneity
SL Goldman, C Hassan, M Khunte, A Soldatenko… - Frontiers in …, 2019 - frontiersin.org
Leukemia, specifically acute myeloid leukemia (AML), is a common malignancy that can be
differentiated into multiple subtypes based on leukemogenic history and etiology. Although …
differentiated into multiple subtypes based on leukemogenic history and etiology. Although …
Addiction of t (8; 21) and inv (16) acute myeloid leukemia to native RUNX1
O Ben-Ami, D Friedman, D Leshkowitz, D Goldenberg… - Cell reports, 2013 - cell.com
Summary The t (8; 21) and inv (16) chromosomal aberrations generate the oncoproteins
AML1-ETO (AE) and CBFβ-SMMHC (CS). The role of these oncoproteins in acute myeloid …
AML1-ETO (AE) and CBFβ-SMMHC (CS). The role of these oncoproteins in acute myeloid …
A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice
Acute myeloid leukemia (AML) is the most common form of adult leukemia. The transcription
factor fusion CBFβ-SMMHC (core binding factor β and the smooth-muscle myosin heavy …
factor fusion CBFβ-SMMHC (core binding factor β and the smooth-muscle myosin heavy …
Chromosomal translocations: revisited yet again
JD Rowley - Blood, The Journal of the American Society of …, 2008 - ashpublications.org
It is hard today, in 2008, when genetic changes in cancer and specifically hematologic
malignancies are accepted as central players, to look back 50 years and realize how …
malignancies are accepted as central players, to look back 50 years and realize how …